The Art of Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Art of Investing

PICK 51.06

+2.3%

4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: stuffbug who wrote (3480)	1/29/2022 11:09:34 AM
From: Sun Tzu	Read Replies (1) of 10711

Thanks. I will have a look at it. And you are right that 2x leveraged funds can be used as intermediate investment options. What I am most interested in are not the drug discovery companies but those that provide the means for drug discover. That can be genom guys like CRSP or NTLA, or it can be platforms like ILMN or NVTA. ARKG is a good hunting ground for such companies, which is why I'd consider it as an investment once it stops falling. Medicine in general is still in the dark ages. We still have a limited understanding of our bodies and don't understand why many drugs work. Which makes most drug discoveries more of an art than science. Computational biology and genomics on the other hand are pure science and subject to the rapid progress in technology.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next